BioXcel Therapeutics (BTAI) IPO Opens Flat

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/13/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

March 8, 2018 10:25 AM UTC

Price: $1.48 -8.07%

Overall Analyst Rating:
SELL (= Flat)

Today's IPO for BioXcel Therapeutics (NASDAQ: BTAI) opened for trading at $11.07 after pricing 5.5 million shares at $11.00.

Barclays, UBS Investment Bank and BMO Capital Markets were lead managers of the offering.

IPOs

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!